Regenerative Medicine Solution for Major Burns

Upside is developing what it believes will be the most advanced and best treatment for severe burns. The Upside product, PelliCel® is a regenerative medicine solution to shortcomings in the current treatment of severe burns patients. Upside will take a small sample of unburnt patient skin and grow it into multiple sheets of differentiated, graftable skin in order to cover the patient’s own burns.

Product advantages are that Upside's PelliCel® is produced faster than any competitive pipeline product, it is supplied in bigger sheets and has good handling characteristics. Upside has intellectual property covering the processes conferring these specific advantages.

Upside Biotechnologies aims to initiate the first clinical trial of PelliCel® at the start of 2022.